RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in RenovoRx, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +2 vs. Q2 2022
- Shares held
- 1.23M
- +42.2K (+3.5%) vs. Q2 2022
- Total value
- $2.49M
- +$134.0K (+5.7%) vs. Q2 2022
- New holders
- 3
- 2 more added
- Sold out
- 1
- 3 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNXT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $9.00M |
| Q1 2026 | 31 | $8.58M |
| Q4 2025 | 33 | $6.83M |
| Q3 2025 | 31 | $9.04M |
| Q2 2025 | 25 | $11.6M |
| Q1 2025 | 27 | $9.98M |
| Q4 2024 | 18 | $1.31M |
| Q3 2024 | 13 | $2.00M |
| Q2 2024 | 17 | $1.01M |
| Q1 2024 | 10 | $441.6K |
| Q4 2023 | 12 | $758.1K |
| Q3 2023 | 14 | $473.5K |
| Q2 2023 | 9 | $552.2K |
| Q1 2023 | 12 | $9.64M |
| Q4 2022 | 11 | $2.75M |
| Q3 2022 | 13 | $2.49M |
| Q2 2022 | 11 | $2.35M |
| Q1 2022 | 12 | $482.0K |
| Q4 2021 | 9 | $506.0K |
| Q3 2021 | 8 | $1.02M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding RenovoRx, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of the West | 975,000 | $1.97M | 0.26% | 00.0% | Unchanged |
| Cohen Lawrence B | 97,165 | $196.0K | 0.15% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 34,302 | $69.0K | 0.00% | +34,302 | New |
| Bank of America Corp | 33,626 | $68.0K | 0.00% | −14,798−30.6% | Reduced |
| Stifel Financial Corp | 31,678 | $64.0K | 0.00% | 00.0% | Unchanged |
| Colony Group LLC | 15,741 | $32.0K | 0.00% | +15,741 | New |
| Cambridge Investment Research Advisors, Inc. | 14,400 | $29.0K | 0.00% | 00.0% | Unchanged |
| Affinity Capital Advisors, LLC | 11,250 | $23.0K | 0.01% | +11,250 | New |
| Vanguard Group Inc | 10,815 | $22.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,494 | $9.00K | 0.00% | +1,813+67.6% | Added |
| UBS Group AG | 1,256 | $3.00K | 0.00% | −4,961−79.8% | Reduced |
| Morgan Stanley | 428 | $1.00K | 0.00% | −1,200−73.7% | Reduced |
| Wells Fargo & Company | 40 | $0 | 0.00% | +24+150.0% | Added |
| Sterling Investment Advisors, Ltd. | 0 | $0 | 0.00% | −20−100.0% | Sold out |